Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
2023 · JHEP Reports · 8 citations
https://doi.org/10.1016/j.jhepr.2023.100966
M
Maria Paola Anolli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
362
Citations
10
h-index
10
i10-index
Maria Paola Anolli is an academic researcher from University of Milan. The author has contributed to research in topics: Hepatitis C virus research & Liver Disease Diagnosis and Treatment & Hepatitis B Virus Studies. The author has an h-index of 10, co-authored 52 publications.
ORCID: 0000-0001-6901-5575Papers by this author
worksHepatitis delta virus (hdv) replication through hbv integrants in hcc recurrence after liver transplantation
2025 · Digestive and Liver Disease · 1 citations
https://doi.org/10.1016/j.dld.2025.01.046
THU-190 Quantitative assessment of anti-mitochondrial antibodies in primary biliary cholangitis: a cross-sectional analysis
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)01158-9
FRI-412 Quantification of plasma hdv rna in untreated and bulevirtidetreated patients with chd: a comparison between robogene 2.0, eurobioplex and altostar
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)02173-1
WED-414 Demographic, virological and clinical features of patients with chronic hepatitis delta treated with bulevirtide: a multicenter italian study (d-shield)
2024 · Journal of Hepatology · 0 citations
https://doi.org/10.1016/s0168-8278(24)02224-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat